antihemophilic factor

Also found in: Thesaurus, Medical, Legal, Financial, Acronyms, Encyclopedia.

Related to antihemophilic factor: Christmas factor, fibrin stabilizing factor

an·ti·he·mo·phil·ic factor

(ăn′tē-hē′mə-fĭl′ĭk, ăn′tī-)

n. Abbr. AHF

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

ThesaurusAntonymsRelated WordsSynonymsLegend:

Switch to new thesaurus

Noun

antihemophilic factor - a coagulation factor (trade name Hemofil) whose absence is associated with hemophilia A

antihaemophilic factor, antihaemophilic globulin, antihemophilic globulin, factor VIII, Hemofil

clotting factor, coagulation factor - any of the factors in the blood whose actions are essential for blood coagulation

Mentioned in ?

References in periodicals archive ?

[ClickPress, Mon Mar 11 2019] Cryoprecipitate also known as cryoprecipitated antihemophilic factor is an insoluble material that emerges from a solution after frozen plasma is defrosted between 1AC and 6AC.

Cryoprecipitated Antihemophilic Factor Market Trends, Regulations And Competitive Landscape Outlook

However, 10-30% of A hemophilic children develop antibodies against factor VIII as a result of replacement therapy, which give rise to significant difficulties [6,8,20]; in these cases, in accordance with the hematologist, the problem can be solved by administering antihemophilic factor A [6].

Dental Management of a Child with Incidentally Detected Hemophilia: Report of a Clinical Case

Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assay procedure.

A comparison study of routine coagulation screening tests (PT and APTT) by three automated coagulation analyzers

ReFacto AF (moroctocog alfa)/XYNTHA (Antihemophilic Factor (Recombinant)) is a recombinant protein drug for treatment and prevention of bleeding in patients with haemophilia A, a rare, chronic, genetic disorder in which the ability of a person's blood to clot is impaired due to missing or reduced levels of a protein known as factor VIII.

SOBI SIGNS MANUFACTURING AGREEMENTS WITH PFIZER

-- Octapharma USA has received Food and Drug Administration approval for Nuwiq, Antihemophilic Factor (Recombinant), an intravenous therapy for adults and children living with hemophilia A.